Versant Capital Management’s BeOne Medicines ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.56K Hold
7
– – ﹤0.01% 2575
2026
Q2
$2K Buy
7
+4
+133% +$1.18K ﹤0.01% 2560
2026
Q1
$891 Buy
+3
New +$971 ﹤0.01% 2665
2023
Q4
– Sell
-8
Closed -$1.44K – 2028
2023
Q3
$1.44K Hold
8
– – ﹤0.01% 1417
2023
Q2
$1.43K Hold
8
– – ﹤0.01% 1498
2023
Q1
$1.72K Buy
+8
New +$1.92K ﹤0.01% 1307

Other funds holding ONC

Versant Capital Management's ONC Position: Q3 2026 in Review

Versant Capital Management held its BeOne Medicines (ONC) position steady in Q3 2026 at 7 shares worth $2.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2575.

Versant Capital Management first reported a position in ONC in Q1 2023 and has held it in 6 quarters since. 325 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Versant Capital Management held 7 shares of BeOne Medicines worth $2.56K as of Q3 2026.
  • Versant Capital Management left its BeOne Medicines share count unchanged in Q3 2026.
  • BeOne Medicines made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2575 holding.
  • Versant Capital Management first reported a position in BeOne Medicines in Q1 2023 and has held it in 6 quarters since.
  • 325 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.